Yesterday the British Medical Journal (BMJ Open) published the facial redness trial results. This is an incredibly significant milestone for the company as it validates the trial design and results. What normally takes years and many millions of dollars has been achieved by HoneyLab in 1 year for a fraction of the cost. We have a safe and effective treatment for facial redness which is a difficult to treat disease.

It is highly unlikely that another New Zealand research paper will be published in the BMJ this year (unless it is one of ours!)

Shaun has championed this R&D and this is the culmination of the work on Honevo. We are hopeful that as a result this will be picked up by major news channels overseas and assist in generating more interest from our target licensees and the consumer public.

Here is the link:

Fingleton J et al. A single-­blind randomised controlled trial of topical kanuka honey for the treatment of facial redness. British Medical Journal Open 2015; 5: e007651